Compare Sana Biotechnology Inc (SANA) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Verisign, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is far larger — about 28.9× Sana Biotechnology Inc's market cap, and Verisign, Inc. pays a 1.17% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | VRSN | |
|---|---|---|
Market Cap | $873.84M | $25.26B |
Sector | Health | Technology |
52-Week High | $5.92 | $310.00 |
52-Week Low | $2.68 | $211.49 |
Enterprise Value | $848.03M | $26.50B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
